
OpGen, Inc
OPGN
OPGN: OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
moreShow OPGN Financials
Recent trades of OPGN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by OPGN's directors and management
Government lobbying spending instances
-
$10,000 Jul 10, 2009 Issue: Defense
-
$20,000 Apr 17, 2009 Issue: Defense
New patents grants
Federal grants, loans, and purchases
Followers on OPGN's company Twitter account
Number of mentions of OPGN in WallStreetBets Daily Discussion
Recent insights relating to OPGN
Recent picks made for OPGN stock on CNBC
ETFs with the largest estimated holdings in OPGN
Flights by private jets registered to OPGN